Autopsy report · NCT01709968
Magnesium Oxide Monohydrate for Nocturnal Leg Cramps
Cause of deathFutility
“Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for futility.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 2 months before it stopped.
- 94 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Uzi Milman
- Sponsor type
- University, hospital or other
- Conditions
- Nocturnal Leg Cramps; Quality of Life
- Interventions
- MAGNOX 520®; placebo
- Participants
- 94
- Sites
- 1
- Countries
- Israel
Trials that died the same way
- CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)
“Study was terminated after the planned interim analysis as the pre-defined futility threshold was met” - Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)
“Based on the outcome of a planned interim analysis, the study was stopped early due to futility.” - Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
“This study was terminated early due to futility.” - Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients
“The study was stopped for futility at the first interim analysis” - Tissue Adhesive vs. Sterile Strips After Cesarean Delivery
“Based on results of an interim analysis, the study was halted for futility”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.